County of Cherokee v. Purdue Pharma L.P. et al
Consolidated
Lead case: 1:17-md-02804
Lead case: 1:17-md-02804
| Ohio Northern District Court | |
| Judge: | Dan Aaron Polster |
| Case #: | 1:17-op-45155 |
| Nature of Suit | 367 Torts - Personal Injury - Health Care/Pharmaceutical Personal Injury/Product Liability |
| Cause | 28:1332 Diversity-Product Liability |
| Case Filed: | Dec 20, 2017 |
| Case in other court: | Texas Eastern, 6:17-cv-00659 |
| Last checked: Friday Nov 08, 2019 4:54 PM EST |
|
Defendant
Purdue Frederick Company, Inc.
|
Represented By
|
|
Defendant
Johnson & Johnson
|
Represented By
|
|
Defendant
McKesson Corporation
|
Represented By
|
|
Defendant
Morris & Dickson Co., LLC
|
|
|
Defendant
Mylan Pharmaceuticals Inc.
|
|
|
Defendant
Ortho-Mcneil-Janssen Pharmaceuticals Inc.
|
Represented By
|
|
Defendant
Par Pharmaceutical Companies, Inc.
|
|
|
Defendant
Par Pharmaceutical, Inc.
|
|
|
Defendant
Janssen Pharmaceuticals Inc.
|
Represented By
|
|
Defendant
Purdue Pharma Inc.
|
Represented By
|
|
Defendant
Purdue Pharma L.P.
|
Represented By
|
|
Defendant
SpecGX LLC
|
|
|
Defendant
Wal-Mart Stores Texas, LLC
|
|
|
Defendant
Walmart Inc.
|
|
|
Defendant
Watson Laboratories Inc.
|
|
|
Defendant
CVS Pharmacy, Inc.
|
|
|
Defendant
AbbVie Inc.
|
|
|
Defendant
Actavis LLC
|
|
|
Defendant
Actavis Pharma, Inc.
|
Represented By
|
|
Defendant
Allergan Finance LLC
|
Represented By
|
|
Defendant
Allergan PLC
|
|
|
Defendant
AmerisourceBergen Corporation
|
Represented By
|
|
Defendant
AmerisourceBergen Drug Corporation
|
|
|
Defendant
CVS Health Corporation
|
|
|
Defendant
Cardinal Health Inc.
|
Represented By
|
|
Defendant
Endo Health Solutions Inc.
|
|
|
Defendant
Endo Pharmaceuticals Inc.
|
|
|
Defendant
Hikma Pharmaceuticals USA Inc.
|
|
|
Defendant
Janssen Pharmaceutica Inc.
|
Represented By
|
|
Plaintiff
County of Cherokee
|
Represented By
|
| TERMINATED PARTIES | |
|
Defendant
Knoll Pharmaceutical Company
Terminated: 03/23/2018
|
|
|
Defendant
Teva Pharmaceutical Industries Ltd.
Terminated: 04/11/2018
|
|
|
Defendant
Teva Pharmaceuticals USA, Inc.
Terminated: 04/11/2018
|
Represented By
|
|
Defendant
Cephalon Inc.
Terminated: 04/11/2018
|
Represented By
|
|
Defendant
Insys Therapeutics, Inc.
Terminated: 03/24/2018
|
Represented By
|
| Docket last updated: 04/08/2019 8:51 PM EDT |
| Monday, November 20, 2017 | ||
| District Judge Robert W. Schroeder, III and Magistrate Judge John D. Love added. (mll, ) [Transferred from txed on 12/20/2017.] | ||
| DEMAND for Trial by Jury by County of Cherokee. (mll, ) [Transferred from txed on 12/20/2017.] | ||
| 1 | 1
COMPLAINT AND JURY DEMAND against All Defendants ( Filing fee $ 400 receipt number 0540-6560291.), filed by County of Cherokee.(Simon, Jeffrey) [Transferred from txed on 12/20/2017.]
|
|
|
Att: 1
Civil Cover Sheet
|
||
| 2 | 2
CASE REFERRED to Magistrate Judge John D Love. (mll, ) [Transferred from txed on 12/20/2017.]
|
|
| Tuesday, November 21, 2017 | ||
| In accordance with the provisions of 28 USC Section 636(c), you are hereby notified that a U.S. Magistrate Judge of this district court is available to conduct any or all proceedings in this case including a jury or non-jury trial and to order the entry of a final judgment. The form[LINK:Consent to Proceed Before Magistrate Judge] is available on our website. All signed consent forms, excluding pro se parties, should be filed electronically using the event Notice Regarding Consent to Proceed Before Magistrate Judge . (mll, ) [Transferred from txed on 12/20/2017.] | ||
| 3 | 3
SUMMONS Issued as to Abbvie Inc., Actavis LLC, Actavis Pharma, Inc., Allergan Finance LLC, AmerisourceBergen Corporation, Cardinal Health, Inc., Cephalon, Inc., Endo Health Solutions, Inc., Endo Pharmaceuticals Inc., Insys Therapeutics, Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Knoll Pharmaceutical Company, McKesson Corporation, Purdue Pharma Inc., Purdue Pharma L.P., Teva Pharmaceuticals USA, Inc., The Purdue Frederick Company, Watson Laboratories, Inc..(mll, ) [Transferred from txed on 12/20/2017.]
|
|
|
Att: 1
Summons(es) Actavis LLC,
|
||
|
Att: 2
Summons(es) Actavis Pharma,
|
||
|
Att: 3
Summons(es) Allergan Finance,
|
||
|
Att: 4
Summons(es) AmerisourceBergen,
|
||
|
Att: 5
Summons(es) Cardinal Health,
|
||
|
Att: 6
Summons(es) Cephalon,
|
||
|
Att: 7
Summons(es) Endo Health Solutions,
|
||
|
Att: 8
Summons(es) Endo Pharmaceuticals,
|
||
|
Att: 9
Summons(es) Insys,
|
||
|
Att: 10
Summons(es) Jassen Pharmaceuticals,
|
||
|
Att: 11
Summons(es) Johnson & Johnson,
|
||
|
Att: 12
Summons(es) Knoll Pharmaceutical,
|
||
|
Att: 13
Summons(es) McKesson,
|
||
|
Att: 14
Summons(es) Purdue Pharma Inc,
|
||
|
Att: 15
Summons(es) Purdue Pharma LP,
|
||
|
Att: 16
Summons(es) Teva USA,
|
||
|
Att: 17
Summons(es) Purdue Frederick,
|
||
|
Att: 18
Summons(es) Watson Labs
|
||
| 4 | 4
NOTICE of Attorney Appearance by John F Walker on behalf of County of Cherokee (Walker, John) [Transferred from txed on 12/20/2017.]
|
|
| 5 | 5
NOTICE of Attorney Appearance by Reid William Martin on behalf of County of Cherokee (Martin, Reid) [Transferred from txed on 12/20/2017.]
|
|
| 6 | 6
NOTICE of Attorney Appearance by Amy M. Carter on behalf of County of Cherokee (Carter, Amy) [Transferred from txed on 12/20/2017.]
|
|
| Thursday, November 30, 2017 | ||
| 7 | 7
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Allergan Finance LLC.( Hill, Jack) [Transferred from txed on 12/20/2017.]
|
|
| 8 | 8
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re AmerisourceBergen Corporation.( Smith, Melissa) [Transferred from txed on 12/20/2017.]
|
|
| Friday, December 01, 2017 | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint is granted pursuant to Local Rule CV-12 for Allergan Finance LLC to 1/17/2018. 30 Days Granted for Deadline Extension.( mjc, ) [Transferred from txed on 12/20/2017.] | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint is granted pursuant to Local Rule CV-12 for AmerisourceBergen Corporation to 1/19/2018. 30 Days Granted for Deadline Extension.( mjc, ) [Transferred from txed on 12/20/2017.] | ||
| 9 | 9
Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re Allergan Finance LLC.( Hill, Jack) [Transferred from txed on 12/20/2017.]
|
|
| 10 | 10
Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re AmerisourceBergen Corporation.( Smith, Melissa) [Transferred from txed on 12/20/2017.]
|
|
| 11 | 11
CORPORATE DISCLOSURE STATEMENT filed by AmerisourceBergen Corporation (Smith, Melissa) [Transferred from txed on 12/20/2017.]
|
|
| 12 | 12
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Purdue Pharma Inc..( Reed, Noelle) [Transferred from txed on 12/20/2017.]
|
|
| 13 | 13
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Purdue Pharma L.P..( Reed, Noelle) [Transferred from txed on 12/20/2017.]
|
|
| 14 | 14
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re The Purdue Frederick Company.( Reed, Noelle) [Transferred from txed on 12/20/2017.]
|
|
| 15 | 15
CORPORATE DISCLOSURE STATEMENT filed by Purdue Pharma Inc., Purdue Pharma L.P., The Purdue Frederick Company [Transferred from txed on 12/20/2017.]
|
|
| 16 | 16
Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re Purdue Pharma Inc..( Reed, Noelle) [Transferred from txed on 12/20/2017.]
|
|
| 17 | 17
Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re Purdue Pharma L.P..( Reed, Noelle) [Transferred from txed on 12/20/2017.]
|
|
| 18 | 18
Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re The Purdue Frederick Company.( Reed, Noelle) [Transferred from txed on 12/20/2017.]
|
|
| Monday, December 04, 2017 | ||
| Defendant's Unopposed Second Application for Extension of Time to Answer Complaint9 is granted pursuant to Local Rule CV-12 for Allergan Finance LLC to 2/1/2018. 15 Days Granted for Deadline Extension.( mll, ) [Transferred from txed on 12/20/2017.] | ||
| Defendant's Unopposed Second Application for Extension of Time to Answer Complaint10 is granted pursuant to Local Rule CV-12 for AmerisourceBergen Corporation to 2/5/2018. 15 Days Granted for Deadline Extension.( mll, ) [Transferred from txed on 12/20/2017.] | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint12 is granted pursuant to Local Rule CV-12 for Purdue Pharma Inc. to 1/17/2018. 30 Days Granted for Deadline Extension.( mll, ) [Transferred from txed on 12/20/2017.] | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint13 is granted pursuant to Local Rule CV-12 for Purdue Pharma L.P. to 1/17/2018. 30 Days Granted for Deadline Extension.( mll, ) [Transferred from txed on 12/20/2017.] | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint14 is granted pursuant to Local Rule CV-12 for The Purdue Frederick Company to 1/17/2018. 30 Days Granted for Deadline Extension.( mll, ) [Transferred from txed on 12/20/2017.] | ||
| Defendant's Unopposed Second Application for Extension of Time to Answer Complaint16 is granted pursuant to Local Rule CV-12 for Purdue Pharma Inc. to 2/1/2018. 15 Days Granted for Deadline Extension.( mll, ) [Transferred from txed on 12/20/2017.] | ||
| Defendant's Unopposed Second Application for Extension of Time to Answer Complaint17 is granted pursuant to Local Rule CV-12 for Purdue Pharma L.P. to 2/1/2018. 15 Days Granted for Deadline Extension.( mll, ) [Transferred from txed on 12/20/2017.] | ||
| Defendant's Unopposed Second Application for Extension of Time to Answer Complaint18 is granted pursuant to Local Rule CV-12 for The Purdue Frederick Company to 2/1/2018. 15 Days Granted for Deadline Extension.( mll, ) [Transferred from txed on 12/20/2017.] | ||
| ***FILED IN ERROR. Documents # 19 and 20 Unopposed Applications for Extension of Time. PLEASE IGNORE.*** (mjc, ) [Transferred from txed on 12/20/2017.] | ||
| 19 | 19
***DOCUMENT FILED IN ERROR. PLEASE DISREGARD.***
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Cardinal Health, Inc..( Geyer, Christopher) Modified on 12/4/2017 (mjc, ). [Transferred from txed on 12/20/2017.]
|
|
| 20 | 20
***DOCUMENT FILED IN ERROR. PLEASE DISREGARD.***
Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re Cardinal Health, Inc..( Geyer, Christopher) Modified on 12/4/2017 (mjc, ). [Transferred from txed on 12/20/2017.]
|
|
| 21 | 21
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Cardinal Health, Inc..( Geyer, Christopher) [Transferred from txed on 12/20/2017.]
|
|
| 22 | 22
Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re Cardinal Health, Inc..( Geyer, Christopher) [Transferred from txed on 12/20/2017.]
|
|
| Tuesday, December 05, 2017 | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint21 is granted pursuant to Local Rule CV-12 for Cardinal Health, Inc. to 1/18/2018. 30 Days Granted for Deadline Extension.( mll, ) [Transferred from txed on 12/20/2017.] | ||
| Defendant's Unopposed Second Application for Extension of Time to Answer Complaint22 is granted pursuant to Local Rule CV-12 for Cardinal Health, Inc. to 2/2/2018. 15 Days Granted for Deadline Extension.( mll, ) [Transferred from txed on 12/20/2017.] | ||
| Monday, December 11, 2017 | ||
| 23 | 23
NOTICE of Attorney Appearance by Stephen Edward McConnico on behalf of Janssen Pharmaceutica Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc. (McConnico, Stephen) [Transferred from txed on 12/20/2017.]
|
|
| 24 | 24
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Janssen Pharmaceuticals, Inc..( McConnico, Stephen) [Transferred from txed on 12/20/2017.]
|
|
| 25 | 25
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Johnson & Johnson.( McConnico, Stephen) [Transferred from txed on 12/20/2017.]
|
|
| 26 | 26
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Janssen Pharmaceutica Inc..( McConnico, Stephen) [Transferred from txed on 12/20/2017.]
|
|
| 27 | 27
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Ortho-McNeil-Janssen Pharmaceuticals, Inc..( McConnico, Stephen) [Transferred from txed on 12/20/2017.]
|
|
| 28 | 28
CORPORATE DISCLOSURE STATEMENT filed by Janssen Pharmaceutica Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc. (McConnico, Stephen) [Transferred from txed on 12/20/2017.]
|
|
| Tuesday, December 12, 2017 | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint24 is granted pursuant to Local Rule CV-12 for Janssen Pharmaceuticals, Inc. to 1/12/2018. 25 Days Granted for Deadline Extension.( mll, ) [Transferred from txed on 12/20/2017.] | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint25 is granted pursuant to Local Rule CV-12 for Johnson & Johnson to 1/12/2018. 30 Days Granted for Deadline Extension.( mll, ) [Transferred from txed on 12/20/2017.] | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint26 is granted pursuant to Local Rule CV-12 for Janssen Pharmaceutica Inc. to 1/12/2018. 25 Days Granted for Deadline Extension.( mll, ) [Transferred from txed on 12/20/2017.] | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint27 is granted pursuant to Local Rule CV-12 for Ortho-McNeil-Janssen Pharmaceuticals, Inc. to 1/12/2018. 25 Days Granted for Deadline Extension.( mll, ) [Transferred from txed on 12/20/2017.] | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint29 is granted pursuant to Local Rule CV-12 for Insys Therapeutics, Inc. to 1/17/2018. 30 Days Granted for Deadline Extension.( mll, ) [Transferred from txed on 12/20/2017.] | ||
| Defendant's Unopposed Second Application for Extension of Time to Answer Complaint31 is granted pursuant to Local Rule CV-12 for Insys Therapeutics, Inc. to 2/1/2018. 15 Days Granted for Deadline Extension.( mll, ) [Transferred from txed on 12/20/2017.] | ||
| 29 | 29
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re INSYS Therapeutics, Inc..(Sarokhanian, Nicholas) [Transferred from txed on 12/20/2017.]
|
|
| 30 | 30
CORPORATE DISCLOSURE STATEMENT filed by Insys Therapeutics, Inc. (Sarokhanian, Nicholas) [Transferred from txed on 12/20/2017.]
|
|
| 31 | 31
Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re INSYS Therapeutics, Inc.(Sarokhanian, Nicholas) [Transferred from txed on 12/20/2017.]
|
|
| Wednesday, December 13, 2017 | ||
| 32 | 32
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re McKesson Corporation.( Scott, Robert) [Transferred from txed on 12/20/2017.]
|
|
| 33 | 33
Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re McKesson Corporation.( Scott, Robert) [Transferred from txed on 12/20/2017.]
|
|
| 34 | 34
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Actavis Pharma, Inc..( Stanfield, Craig) [Transferred from txed on 12/20/2017.]
|
|
| 35 | 35
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Cephalon, Inc..( Stanfield, Craig) [Transferred from txed on 12/20/2017.]
|
|
| 36 | 36
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Teva Pharmaceuticals USA, Inc..( Stanfield, Craig) [Transferred from txed on 12/20/2017.]
|
|
| 37 | 37
CORPORATE DISCLOSURE STATEMENT filed by Cephalon, Inc., Teva Pharmaceuticals USA, Inc. (Stanfield, Craig) [Transferred from txed on 12/20/2017.]
|
|
| 38 | 38
CORPORATE DISCLOSURE STATEMENT filed by Actavis Pharma, Inc. identifying Corporate Parent Teva Pharmaceuticals Industries, Ltd. for Actavis Pharma, Inc.. (Stanfield, Craig) [Transferred from txed on 12/20/2017.]
|
|
| Thursday, December 14, 2017 | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint32 is granted pursuant to Local Rule CV-12 for McKesson Corporation to 1/17/2018. 30 Days Granted for Deadline Extension.( mll, ) [Transferred from txed on 12/20/2017.] | ||
| Defendant's Unopposed Second Application for Extension of Time to Answer Complaint33 is granted pursuant to Local Rule CV-12 for McKesson Corporation to 2/1/2018. 15 Days Granted for Deadline Extension.( mll, ) [Transferred from txed on 12/20/2017.] | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint34 is granted pursuant to Local Rule CV-12 for Actavis Pharma, Inc. to 1/17/2018. 30 Days Granted for Deadline Extension.( mll, ) [Transferred from txed on 12/20/2017.] | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint35 is granted pursuant to Local Rule CV-12 for Cephalon, Inc. to 1/18/2018. 30 Days Granted for Deadline Extension.( mll, ) [Transferred from txed on 12/20/2017.] | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint36 is granted pursuant to Local Rule CV-12 for Teva Pharmaceuticals USA, Inc. to 1/18/2018. 30 Days Granted for Deadline Extension.( mll, ) [Transferred from txed on 12/20/2017.] | ||
| 39 | 39
CONDITIONAL TRANSFER ORDER. This civil action is transferred to the Northern District of Ohio and to the docket of the Honorable Dan A. Polster.
MDL 2804 IN RE: NATIONAL PRESCRIPTION OPIATE LITIGATION (mll, ) [Transferred from txed on 12/20/2017.]
|
|
| Friday, December 15, 2017 | ||
| Interdistrict transfer to the Northern District of Ohio. MDL 2804 IN RE: NATIONAL PRESCRIPTION OPIATE LITIGATION. (mll, ) [Transferred from txed on 12/20/2017.] | ||
| Wednesday, December 20, 2017 | ||
| 40 | 40
CASE TRANSFERRED IN from District of Texas Eastern. Case number 6:17-cv-00659. Original file, certified copy of transfer order and docket sheet received.
|
|